12/08/2018
ImmunoSite Technologies has transferred to Miami-Dade County! Please note the new addresses and effective dates below: Mailing Address (Effective Date: December 1, 2018): P.O. Box 165937, Miami, FL 33116, USA Shipping Address (Effective Date: December 10, 2018): 4981 SW 74 Court, Miami, FL 33155, USA Share this:

11/01/2011
Tags:
Immune MonitoringWorking together, ImmunoSite Technologies and Goodwin Biotechnology companies offer enhanced abilities to develop, test and manufacture biopharmaceuticals

09/27/2011
Tags:
Cell Mediated Immune Assays,
clinical research,
Immune Monitoring,
IST Partnerships,
Vaccine DevelopmentWorking together, companies offer enhanced abilities to monitor immunotherapy response in vaccine and drug studies.

12/07/2010
A Commitment to Ensure Compliance The entire IST organization operates with a full quality system compliant with GLP guidelines and relevant international safety regulatory requirements. IST’s “state-of-the-art” facilities for immune monitoring, cell mediated immunity, particle testing, automation, and particle characterization, meet cGLP standards, and are in the process of obtaining CLIA certification. Key to meeting cGLP […]
